Welcome to AMYPAD!

We are a collaborative research initiative aiming to improve the understanding, diagnosis and management of Alzheimer’s disease through the utilisation of ß-amyloid PET imaging.

The Amyloid imaging to prevent Alzheimer’s disease (AMYPAD) initiative aims to:

 

→ About Us

 

→ Our papers

 

Homepage Image Neuraceq™ (left) and Vizamyl™ (right). Upper images: amyloid negative scans. Lower images: amyloid positive scans.
Latest News
Welcome to the 18th issue of the AMYPAD newsletter
Welcome to the 18th issue of the AMYPAD newsletter 03 Sep 2021 September brings everyone back from their holidays so hope you are all suitably rested and ready to go again......
Two AMYPAD researchers successfully defended their PhD thesis
Two AMYPAD researchers successfully defended their PhD thesis 01 Sep 2021 Lyduine Collij and Gemma Salvadó successfully defended their PhD thesis in July 2021. We are proud of their contributions and all their hard work......
Recruitment update
Recruitment update 31 Aug 2021 AMYPAD PHNS: currently 1.075 participants recruited of which 1.002 have been scanned......
Recruitment status (as 31 August, 2021)
Recruitment status (as 31 August, 2021)